Atea Pharmaceuticals Inc (NASDAQ:AVIR) currently has a daily average trading volume of 440.33K but it saw 286948 shares traded in last market. With a market cap of 320.07M USD, the company’s current market price of $3.74 came rising about 3.17 while comparing to the previous closing price of $3.62. In past 52 weeks, the stock remained buoying in the range of price level as high as $4.14 and as low as $2.45. In the recent trading on the day, stock has struck highest price mark of $3.65 while lowest mark touched by it was $3.7599.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Morgan Stanley which upgraded the stock as “Equal-Weight” in its note to investors issued on August 13, 2024, recommending a price target of between $2 and $6.88 for it. Morgan Stanley issued its recommendations for the stock as it downgraded the price target for the stock in the range of between $14 and $7.
Over the week, AVIR’s stock price is moving 5.95% up while it is 16.15% when we observe its performance for the past one month. Year-to-date it is 10.98% up and over the past year, the stock is showing an upside performance of 11.64%.
Currently, Atea Pharmaceuticals Inc’s total number of outstanding shares is 85.58M. Company’s return on investment (ROI) stands at -33.88% and return on equity (ROE) at -30.47%. Stock’s beta reads 0.25. Stock has a price to book (P/B) ratio of 0.78. Its return on asset (ROA) is -28.09% on average.
